{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:30:01Z","timestamp":1794583801706,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46158-w","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:56:24Z","timestamp":1776722184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LDHA-driven ACAA2 lactylation at K270 reprograms fatty acid metabolism to promote clear cell renal cell carcinoma progression"],"prefix":"10.1038","volume":"16","author":[{"given":"Yong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"46158_CR1","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh, J. J. et al. Renal cell carcinoma. Nat. reviews Disease primers. 3, 17009. https:\/\/doi.org\/10.1038\/nrdp.2017.9 (2017).","journal-title":"Nat. reviews Disease primers"},{"key":"46158_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina, L. et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur. Urol. 82, 529\u2013542. https:\/\/doi.org\/10.1016\/j.eururo.2022.08.019 (2022).","journal-title":"Eur. Urol."},{"key":"46158_CR3","doi-asserted-by":"publisher","unstructured":"El-Zaatari, Z. M. & Truong, L. D. Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update. Biomedicines 10, (2022). https:\/\/doi.org\/10.3390\/biomedicines10030657","DOI":"10.3390\/biomedicines10030657"},{"key":"46158_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg, B. et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur. Urol. 82, 399\u2013410. https:\/\/doi.org\/10.1016\/j.eururo.2022.03.006 (2022).","journal-title":"Eur. Urol."},{"key":"46158_CR5","doi-asserted-by":"publisher","unstructured":"Hu, J. et al. Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal. Transduct. Target. therapy. 8 https:\/\/doi.org\/10.1038\/s41392-023-01362-2 (2023).","DOI":"10.1038\/s41392-023-01362-2"},{"key":"46158_CR6","doi-asserted-by":"publisher","unstructured":"Siegel, R. L., Miller, K. D., Jemal, A. & Cancer statistics CA: a cancer journal for clinicians 68, 7\u201330, (2018). https:\/\/doi.org\/10.3322\/caac.21442 (2018).","DOI":"10.3322\/caac.21442"},{"key":"46158_CR7","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1007\/s00432-022-04352-z","volume":"149","author":"C Franzese","year":"2023","unstructured":"Franzese, C. et al. The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma. J. Cancer Res. Clin. Oncol. 149, 4411\u20134417. https:\/\/doi.org\/10.1007\/s00432-022-04352-z (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"46158_CR8","doi-asserted-by":"publisher","first-page":"188559","DOI":"10.1016\/j.bbcan.2021.188559","volume":"1876","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K. & Pal, S. Metabolic reprogramming in renal cancer: Events of a metabolic disease. Biochim. et Biophys. acta Reviews cancer. 1876, 188559. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188559 (2021).","journal-title":"Biochim. et Biophys. acta Reviews cancer"},{"key":"46158_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semnephrol.2018.01.006","volume":"38","author":"RH Weiss","year":"2018","unstructured":"Weiss, R. H. Metabolomics and Metabolic Reprogramming in Kidney Cancer. Semin. Nephrol. 38, 175\u2013182. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.01.006 (2018).","journal-title":"Semin. Nephrol."},{"key":"46158_CR10","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1158\/2159-8290.Cd-21-0211","volume":"11","author":"R Riscal","year":"2021","unstructured":"Riscal, R. et al. Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma. Cancer Discov. 11, 3106\u20133125. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0211 (2021).","journal-title":"Cancer Discov."},{"key":"46158_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","volume":"20","author":"SK Tan","year":"2023","unstructured":"Tan, S. K., Hougen, H. Y., Merchan, J. R., Gonzalgo, M. L. & Welford, S. M. Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets. Nat. Rev. Urol. 20, 48\u201360. https:\/\/doi.org\/10.1038\/s41585-022-00654-6 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"46158_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2174\/1871530320666191230141110","volume":"20","author":"AA Khan","year":"2020","unstructured":"Khan, A. A., Allemailem, K. S., Alhumaydhi, F. A., Gowder, S. J. T. & Rahmani, A. H. The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism. Endocr. Metab. Immune Disord. Drug Targets. 20, 855\u2013868. https:\/\/doi.org\/10.2174\/1871530320666191230141110 (2020).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"46158_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.21873\/anticanres.11435","volume":"37","author":"N Mack","year":"2017","unstructured":"Mack, N., Mazzio, E. A., Bauer, D., Flores-Rozas, H. & Soliman, K. F. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival. Anticancer Res. 37, 1205\u20131212. https:\/\/doi.org\/10.21873\/anticanres.11435 (2017).","journal-title":"Anticancer Res."},{"key":"46158_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","volume":"87","author":"D Sharma","year":"2022","unstructured":"Sharma, D., Singh, M. & Rani, R. Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics. Sem. Cancer Biol. 87, 184\u2013195. https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.007 (2022).","journal-title":"Sem. Cancer Biol."},{"key":"46158_CR15","doi-asserted-by":"publisher","unstructured":"Urba\u0144ska, K. & Orzechowski, A. Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20092085 (2019).","DOI":"10.3390\/ijms20092085"},{"key":"46158_CR16","doi-asserted-by":"publisher","first-page":"936767","DOI":"10.3389\/fonc.2022.936767","volume":"12","author":"J Wu","year":"2022","unstructured":"Wu, J., Chen, Y., Lin, Y., Lan, F. & Cui, Z. Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer. Front. Oncol. 12, 936767. https:\/\/doi.org\/10.3389\/fonc.2022.936767 (2022).","journal-title":"Front. Oncol."},{"key":"46158_CR17","doi-asserted-by":"publisher","first-page":"e15749","DOI":"10.7717\/peerj.15749","volume":"11","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. The novel role of LDHA\/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma. PeerJ 11, e15749. https:\/\/doi.org\/10.7717\/peerj.15749 (2023).","journal-title":"PeerJ"},{"key":"46158_CR18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","volume":"42","author":"H Li","year":"2024","unstructured":"Li, H., Sun, L., Gao, P. & Hu, H. Lactylation in cancer: Current understanding and challenges. Cancer cell. 42, 1803\u20131807. https:\/\/doi.org\/10.1016\/j.ccell.2024.09.006 (2024).","journal-title":"Cancer cell."},{"key":"46158_CR19","doi-asserted-by":"publisher","unstructured":"Chen, J. et al. Lactate and lactylation in cancer. Signal. Transduct. Target. therapy. 10 https:\/\/doi.org\/10.1038\/s41392-024-02082-x (2025).","DOI":"10.1038\/s41392-024-02082-x"},{"key":"46158_CR20","doi-asserted-by":"publisher","unstructured":"Agudelo, J. P. et al. Multiparametric Magnetic Resonance Imaging and Metabolic Characterization of Patient-Derived Xenograft Models of Clear Cell Renal Cell Carcinoma. Metabolites 12, (2022). https:\/\/doi.org\/10.3390\/metabo12111117","DOI":"10.3390\/metabo12111117"},{"key":"46158_CR21","doi-asserted-by":"publisher","first-page":"216285","DOI":"10.1016\/j.canlet.2023.216285","volume":"567","author":"M Chen","year":"2023","unstructured":"Chen, M. et al. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma. Cancer Lett. 567, 216285. https:\/\/doi.org\/10.1016\/j.canlet.2023.216285 (2023).","journal-title":"Cancer Lett."},{"key":"46158_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbrc.2022.05.028","volume":"615","author":"F Nian","year":"2022","unstructured":"Nian, F. et al. LDHA promotes osteoblast differentiation through histone lactylation. Biochem. Biophys. Res. Commun. 615, 31\u201335. https:\/\/doi.org\/10.1016\/j.bbrc.2022.05.028 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"46158_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneph.2017.59","volume":"13","author":"HI Wettersten","year":"2017","unstructured":"Wettersten, H. I., Aboud, O. A., Lara, P. N. Jr. & Weiss, R. H. Metabolic reprogramming in clear cell renal cell carcinoma. Nat. Rev. Nephrol. 13, 410\u2013419. https:\/\/doi.org\/10.1038\/nrneph.2017.59 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"46158_CR24","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/mc.23729","volume":"63","author":"Y Leng","year":"2024","unstructured":"Leng, Y. et al. The oncogenic role and regulatory mechanism of ACAA2 in human ovarian cancer. Mol. Carcinog. 63, 1362\u20131377. https:\/\/doi.org\/10.1002\/mc.23729 (2024).","journal-title":"Mol. Carcinog."},{"key":"46158_CR25","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41419-022-05344-0","volume":"13","author":"M Yang","year":"2022","unstructured":"Yang, M. et al. Bromodomain-containing protein 4 (BRD4) as an epigenetic regulator of fatty acid metabolism genes and ferroptosis. Cell Death Dis. 13, 912. https:\/\/doi.org\/10.1038\/s41419-022-05344-0 (2022).","journal-title":"Cell Death Dis."},{"key":"46158_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10555-021-09996-w","volume":"41","author":"G Heravi","year":"2022","unstructured":"Heravi, G., Yazdanpanah, O., Podgorski, I., Matherly, L. H. & Liu, W. Lipid metabolism reprogramming in renal cell carcinoma. Cancer Metastasis Rev. 41, 17\u201331. https:\/\/doi.org\/10.1007\/s10555-021-09996-w (2022).","journal-title":"Cancer Metastasis Rev."},{"key":"46158_CR27","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.3892\/mmr.2017.7637","volume":"16","author":"J 27 Zhao","year":"2017","unstructured":"27 Zhao, J. et al. LDHA promotes tumor metastasis by facilitating epithelial\u2013mesenchymal transition in renal cell carcinoma. Mol. Med. Rep. 16, 8335\u20138344. https:\/\/doi.org\/10.3892\/mmr.2017.7637 (2017).","journal-title":"Mol. Med. Rep."},{"key":"46158_CR28","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.2147\/ott.S241717","volume":"13","author":"L Shi","year":"2020","unstructured":"Shi, L., An, S., Liu, Y., Liu, J. & Wang, F. PCK1 Regulates Glycolysis and Tumor Progression in Clear Cell Renal Cell Carcinoma Through LDHA. OncoTargets therapy. 13, 2613\u20132627. https:\/\/doi.org\/10.2147\/ott.S241717 (2020).","journal-title":"OncoTargets therapy"},{"key":"46158_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41419-024-06450-x","volume":"15","author":"R Liu","year":"2024","unstructured":"Liu, R. et al. FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2\u03b1 blockade by facilitating LDHA phosphorylation. Cell Death Dis. 15, 64. https:\/\/doi.org\/10.1038\/s41419-024-06450-x (2024).","journal-title":"Cell Death Dis."},{"key":"46158_CR30","doi-asserted-by":"publisher","unstructured":"Lin, C. S. et al. Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma. Int. J. Mol. Sci. 17 https:\/\/doi.org\/10.3390\/ijms17060814 (2016).","DOI":"10.3390\/ijms17060814"},{"key":"46158_CR31","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1158\/0008-5472.Can-15-1859","volume":"76","author":"D Sch\u00f6nenberger","year":"2016","unstructured":"Sch\u00f6nenberger, D. et al. Formation of Renal Cysts and Tumors in Vhl\/Trp53-Deficient Mice Requires HIF1\u03b1 and HIF2\u03b1. Cancer Res. 76, 2025\u20132036. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-1859 (2016).","journal-title":"Cancer Res."},{"key":"46158_CR32","doi-asserted-by":"publisher","first-page":"e3002666","DOI":"10.1371\/journal.pbio.3002666","volume":"22","author":"X Hou","year":"2024","unstructured":"Hou, X. et al. KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation. PLoS Biol. 22, e3002666. https:\/\/doi.org\/10.1371\/journal.pbio.3002666 (2024).","journal-title":"PLoS Biol."},{"key":"46158_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/s0022029919000992","volume":"87","author":"S Symeou","year":"2020","unstructured":"Symeou, S., Tzamaloukas, O., Banos, G. & Miltiadou, D. ACAA2 and FASN polymorphisms affect the fatty acid profile of Chios sheep milk. J. Dairy. Res. 87, 23\u201326. https:\/\/doi.org\/10.1017\/s0022029919000992 (2020).","journal-title":"J. Dairy. Res."},{"key":"46158_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer. 122, 4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z (2020).","journal-title":"Br. J. Cancer"},{"key":"46158_CR35","doi-asserted-by":"publisher","first-page":"216724","DOI":"10.1016\/j.canlet.2024.216724","volume":"587","author":"D Murthy","year":"2024","unstructured":"Murthy, D. et al. CD24 negativity reprograms mitochondrial metabolism to PPAR\u03b1 and NF-\u03baB-driven fatty acid \u03b2-oxidation in triple-negative breast cancer. Cancer Lett. 587, 216724. https:\/\/doi.org\/10.1016\/j.canlet.2024.216724 (2024).","journal-title":"Cancer Lett."},{"key":"46158_CR36","doi-asserted-by":"publisher","first-page":"110838","DOI":"10.1016\/j.cellsig.2023.110838","volume":"110","author":"K Zeng","year":"2023","unstructured":"Zeng, K. et al. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS\/PPAR\u03b3\/NF-\u03baB pathway in clear cell renal cell carcinoma. Cell. Signal. 110, 110838. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110838 (2023).","journal-title":"Cell. Signal."},{"key":"46158_CR37","doi-asserted-by":"publisher","first-page":"484e489","DOI":"10.1016\/j.urology.2012.02.046","volume":"80","author":"B Jiang","year":"2012","unstructured":"Jiang, B. et al. Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer. Urology 80, 484e489\u2013484e415. https:\/\/doi.org\/10.1016\/j.urology.2012.02.046 (2012).","journal-title":"Urology"},{"key":"46158_CR38","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1042\/cs20190587","volume":"133","author":"S Cheng","year":"2019","unstructured":"Cheng, S. et al. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR\u03b3-mediated pathway in bladder cancer. Clin. Sci. (London England: 1979). 133, 1745\u20131758. https:\/\/doi.org\/10.1042\/cs20190587 (2019).","journal-title":"Clin. Sci. (London England: 1979)"},{"key":"46158_CR39","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1194\/jlr.M800666-JLR200","volume":"50","author":"NL Alderson","year":"2009","unstructured":"Alderson, N. L. & Hama, H. Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T schwannoma cells. J. Lipid Res. 50, 1203\u20131208. https:\/\/doi.org\/10.1194\/jlr.M800666-JLR200 (2009).","journal-title":"J. Lipid Res."},{"key":"46158_CR40","doi-asserted-by":"publisher","first-page":"e11849","DOI":"10.1002\/advs.202411849","volume":"12","author":"Z Cui","year":"2025","unstructured":"Cui, Z. et al. Lactate Dehydrogenase C4 Accelerates Triple-Negative Breast Cancer Progression by Promoting Acetyl-CoA Acyltransferase 2 Lactylation to Increase Free Fatty Acid Accumulation. Adv. Sci. 12, e11849. https:\/\/doi.org\/10.1002\/advs.202411849 (2025).","journal-title":"Adv. Sci."},{"key":"46158_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13046-023-02607-2","volume":"42","author":"TTM Nguyen","year":"2023","unstructured":"Nguyen, T. T. M. et al. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT. J. experimental Clin. cancer research: CR. 42, 42. https:\/\/doi.org\/10.1186\/s13046-023-02607-2 (2023).","journal-title":"J. experimental Clin. cancer research: CR"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46158-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T22:39:01Z","timestamp":1781476741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46158-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46158"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46158-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18406"}}